LIP-C Injection Dosage Chart: Why There Is No Universal One

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub, our resource for evidence-based guidance on longevity protocols, peptide therapies, and the genetics behind metabolic decisions. Browse all Peptides & Longevity education for more.

The appeal of a LIP-C injection dosage chart is obvious: one table that answers the dosing question. In practice, LIP-C dosing is determined by a prescribing provider based on individual factors, indication, and tolerability, so a single chart cannot substitute for that judgment. This article explains why, reports the general context responsibly, and covers the genetics underneath — without providing specific dosing direction, which belongs in your clinical conversation.

Why a single chart does not exist

A universal chart would imply that one number fits every patient, but dosing depends on the person and the compound in front of them. Specific LIP-C dosing is set by a prescribing provider based on indication, individual factors, and tolerability. The clinical literature reports typical adult dosing ranges and FDA-approved labeling exists where applicable, yet translating those into a personal dose is a clinical task, not a chart lookup.

What a chart cannot capture

A static table cannot account for medical history, goals, concurrent factors, or how someone tolerates the compound over time. Those are exactly the inputs a prescriber weighs, which is why this article does not provide specific dosing direction.

What LIP-C is

LIP-C, also called Lipo-C, is a compounded lipotropic injection that typically combines methionine, inositol, choline, vitamin B12, and L-carnitine. The lipotropic agents support fat utilization and methylation, while L-carnitine supports fatty-acid transport into mitochondria. Because it is compounded, formulations vary by compounding pharmacy and prescriber order — one more reason a single chart cannot apply across the board.

How LIP-C works

LIP-C acts on methylation, choline metabolism, and lipotropic fat utilization. Effects studied in this space are mediated through specific enzymatic pathways rather than one mechanism, and the pharmacology is described in the peer-reviewed literature. Clinical effect sizes vary with indication, individual factors, and adherence, which further explains why dosing is individualized.

The genetic variable

Variants in MTHFR, PEMT, and CHDH shape the baseline biology LIP-C acts on, influencing methylation, choline metabolism, and lipotropic fat utilization. These pathway-level variants describe the metabolic terrain a clinician is prescribing into; they never provide compound-specific dose recommendations and never predict drug response. PlexusDx offers LIP-C through its Longevity Protocols; see the LIP-C product page for details. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights — including MTHFR, PEMT, and CHDH — through 503A compounding pathways only.

Keep reading on PlexusDx: What Is GLP-1, GLP-1 Hormone, and GLP-1 Receptor Agonist.

How a provider actually sets a dose

In place of a chart, a provider works through a short sequence: identify the indication, review your medical history and concurrent factors, consider the specific compounded formulation, and then choose a starting point with tolerability in mind. Each of those steps is individual, which is precisely why a one-size table would mislead more than it would help.

The formulation variability adds another layer. Because compounded LIP-C can differ by pharmacy, even two prescriptions labeled the same way may not be identical, so a number copied from a generic chart could apply to a different preparation entirely.

Reading dosing content responsibly

When you encounter dosing figures online, treat them as background context rather than instructions. Reference ranges from the clinical literature exist, but they are inputs a clinician interprets. This article deliberately withholds specific direction so the decision stays where it belongs, in your clinical conversation.

In short, the absence of a universal chart is a feature, not a gap. It reflects that safe dosing is a clinical judgment tuned to the individual and the exact preparation in hand. The most useful step a reader can take is to bring their questions to a prescriber who can turn general context into a plan built for them.

Frequently Asked Questions

Is there an official LIP-C dosage chart?

No single official chart applies to everyone. Typical LIP-C dosing varies by compound, indication, and individual factors, and clinical literature and FDA labeling provide reference ranges where applicable. Specific dosing direction is determined by your prescribing provider based on your medical history, goals, and tolerability.

Why can't a blog just list the numbers?

Because a static list would imply one dose fits all patients, which is not how individualized dosing works. A prescriber weighs your medical history, concurrent factors, and tolerability to set and adjust a dose. This article intentionally does not provide specific dosing direction for that reason.

What determines my LIP-C dose?

Your prescribing provider determines it based on indication, individual factors, and tolerability, informed by clinical literature and FDA labeling where applicable. Formulations also vary by compounding pharmacy, which adds another individualized variable. The dose is a clinical decision, not something a chart can standardize across patients.

Does genetic testing produce a dosing chart?

No. Genetic testing does not provide compound-specific dose recommendations. The Precision Peptide Genetic Test analyzes pathway-level variants in MTHFR, PEMT, and CHDH that shape baseline methylation biology, offering upstream context for protocol decisions. Specific dosing belongs in a clinical conversation with your prescribing provider.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.